Cultural Challenges of BlueBird Bio Expansion into Germany by Ban, Igor
Journal of Global Awareness 
Volume 1 
Number 2 Fall/Winter 2020 Article 6 
December 2020 
Cultural Challenges of BlueBird Bio Expansion into Germany 
Igor Ban 
St. Johns's University 
Follow this and additional works at: https://scholar.stjohns.edu/jga 
 Part of the International Business Commons, International Economics Commons, and the 
International Relations Commons 
Recommended Citation 
Ban, Igor (2020) "Cultural Challenges of BlueBird Bio Expansion into Germany," Journal of Global 
Awareness: Vol. 1 : No. 2 , Article 6. 
Available at: https://scholar.stjohns.edu/jga/vol1/iss2/6 
This Article is brought to you for free and open access by St. John's Scholar. It has been accepted for inclusion in 
Journal of Global Awareness by an authorized editor of St. John's Scholar. For more information, please contact 
fazzinol@stjohns.edu. 
Abstract 
BlueBird Bio is a biotechnology multinational corporation (MNC), with 
headquarters in Cambridge, Massachusetts, specializing in gene therapy solutions 
for autoimmune diseases and cancer. The company was recently approved, in 
Germany, for their new drug Zynteglo for the treatment of betta thalassemia. This 
approval opened the door for further investment in the European market, starting 
with the contracting of Apceth Biopharma and purchases of new land and 
equipment to establish a permanent residence in the country. The opening of the 
new European headquarters will demonstrate new challenges for BlueBird Bio, as 
cultural and institutional differences between the host country and parent country 
are quite distinctive. Some of the main differences among countries are their 
cultural dimensions in dealing with risk, masculinity, and indulgence. Unlike the 
United States, Germany is risk avert, values input of all in decision-making, and 
has a general attitude following the best practice approach. The US focuses on the 
individual dimension of a culture where employees are valued for their 
independence. Furthermore, the differences between governmental policies in the 
two countries vary strongly. The German government has strict policies on 
employee protection and can affect the decision making of the organization. There 
is also the presence of labor unions and collective bargaining; two aspects of 
organizational structure US-based companies are trying to avoid. BlueBird Bio is 
an emerging MNC, and its success depends upon its ability to recognize the 
differences in cultures and institutions between the countries. The company has 
already been exposed to multiple countries in Europe and has strong programs in 
employee education supplemented with strong company benefits for its employees, 
which is providing excellent groundwork for establishing headquarters in Germany. 
Keywords: biotechnology, cultural dimensions, federal drug administration, host 
country national, human resource management, individualism, multinational 
corporations, parent country national, T-Cells treatment 
  
Introduction  
BlueBird Bio is a biotechnology multinational corporation founded in Cambridge, 
Massachusetts. They specialize in gene therapy solutions for genetic diseases and 
cancer. Since its founding in 1992, the company went through some changes and 
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acquisitions and became BlueBird Bio in 2010. The IPO was first given in 2013, 
when the company was able to raise $116 million. Since then, the company was 
working in both supportive and primary research capacities by either lending their 
skills to conduct services for larger corporations or developing their own treatments 
for genetic diseases. The company is reaching into many European countries, 
including France, Netherlands, Switzerland, United Kingdom, Italy, and Germany; 
the headquarters remains in the founding city of Cambridge in the United States. 
Larger corporations, such as Regeneron, have collaborated with BlueBird Bio in 
developing targeting antibodies for T-Cell mediated myeloma cancer therapies. 
Due to the shorter path to market in the European Union (EU) compared to the US, 
Bluebird bio was able to seek approval faster and initiate therapies. This type of 
action is common as requirements for approval are less rigorous, and the time is 
150 days compared to the federal drug administration (FDA) mandated 6-12 
months (Nagai, 2019). The EU approval of BlueBird Bio's Zynteglo, for treatment 
of beta thalassemia, was a huge milestone for the company in their efforts to access 
the booming gene therapy market.  
Zyntengo rollout was temporarily contracted to Apceth Biopharma, a German 
manufacturer, but significant investment funds are being spent to acquire in-house 
production capabilities such as purchases of equipment and land leases in Germany. 
Since this will be the production center of the region, significant focus needs to be 
put on Human Resource Management (HRM) for transitioning and stating policies 
between the ones known in the country of origin, in the US, to the expanding branch 
in Germany. The choice of the country of Germany was made partly by the 
estimated population of patients suffering from the disease and partly by the market 
high skill set of host country nationals that can produce treatments.  
Expansion and Challenges in the New Market 
Upon EU approval for treatment, BlueBird Bio has launched the first treatments of 
Zynetglo for patients with betta thalassemia on January 31st. In Germany, the 
estimated number of registered patients with the disease is 632 (Borchert et al., 
2018), and BlueBird Bio claims to be able to deliver treatments for 50 percent of 
the patient population. At the cost of $1.8 million per full treatment cycle, Zynteglo 
is the second most expensive treatment currently in production; however, insurance 
companies are given the option of increment payments and cancellation of charge 
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due to no improvement in patients' health. Furthermore, as BlueBird Bio is the sole 
provider of a cure for beta thalassemia, a rise to full market dominance for treating 
the disease is expected.  
Zynteglo revenues are not expected until the second quarter of 2020, and there are 
considerable expenses in expansion and asset acquisition as production is expected 
to increase. BlueBird Bio has secured contracts for coverage from several insurance 
agencies and is expected to deliver treatments in the first half of 2020.  
The expansion into the market and establishing production capacity will derive a 
set of challenges for the US-based MNC. Challenges in Germany's laws and 
regulations will include the focus on diversified quality production (DQP) and low 
authoritative coordination, where management consults with subordinates and 
involves them in decision-making. DQP is a path of industrial development, or 
restructuring, different from and considered superior to other forms of production, 
including the US-based Ford mass production. German employees have strong 
occupational identity and loyalty and, since it is difficult for management to 
coordinate work on complex tasks, decision-making is delegated to local units 
(Colbe, 1996). Furthermore, the increased involvement of the government in 
mandating policies benefitting employees, as well as regulations that give influence 
in the organization's decision-making, will establish itself as a formidable task for 
BlueBird Bio. 
Currently, the production of reprogrammed T-cells is conducted through sub-
contractors within Germany. BlueBird bio has acquired assets for expansion in the 
European country. This expansion will bring forth challenges in HRM as now more 
encompassing policies need to be set up to satisfy the host country requirements of 
the new production facility. These new challenges will be both cultural and 
institutional. 
The cultural challenges that contain the differences between the US and Germany 
are uncertainty avoidance and individualism (Hofstede, 2001; Bhagat, 2002). 
Cultures with high scores of uncertainty avoidance demonstrates how people in a 
culture cope with the unpredictable and the ambiguous, how they deal with a lack 
of knowledge about the future, and to what extent they experience fear of the 
unknown (Hofstede, 2001). Consequently, organizations in this culture will show 
elements in place to combat such uncertainty by using technology, rules, and rituals 
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(Barr and Glynn, 2004). The cultural dimension can be assigned a value and 
compared by using the Uncertainty Avoidance Index (UAI). Germany, for instance, 
scored high on the UAI, while the United States have a relatively low UAI score 
(Lehmann-Willenbrock, 2013). This translates into behavior. Germans are more 
likely to carefully analyze problems and critically evaluate possible alternatives, 
whereas people in the US may spend less time analyzing problems and therefore 
may produce solutions; in terms of risk, it means Germans are less prone to risk 
taking.  
The second cultural dimension, individualism, is where there is a second large gap 
between the two countries. In strongly individualistic cultures, such as the US, each 
team member's ideas are deemed important, so teams encourage the expression of 
original ideas, whereas, in collectivistic cultures, teams tend to value consensus and 
loyalty over individual inventiveness (Lehmann-Willenbrock, 2013). Even though 
both Germany and the US are both considered individualistic countries, the US 
scores at the very high end of the individualism index compared to Germany, which 
is located close to the middle. Such differences are easily noticeable. 
Germany has a strong institution system, which legally imposes a uniform set of 
institutional arrangements on companies and/or provides incentives for employers 
to accept institutional constraints. The key labor and international relations 
institutions of multi-employer collective bargaining, co-determination, and initial 
vocational training exert pressures to follow a pluralist HRM and IR strategy 
(Muller, 1998; Backes-Gellner et al., 2015). 
Leadership Styles and Practices 
The leadership style in Germany is focused on the practice of minimizing 
uncertainty (Goerke & Pannenberg, 2011). This can be observed by the 
interpretations of "effective German leaders" being characterized by high-
performance orientation, low compassion, low self-protection, low team 
orientation, high autonomy, and high participation (Broadbeck et al., 2002). There 
is certain "respect for competence" in the workforce, which can be seen through 
promoting managers who draw their experience from being engineers, mechanics, 
technicians, doctors, and other staff members who climbed up the ladder solely on 
their job competency; it is noteworthy that managers can all trace their work 
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experience to a point when they had hands-on experience. The guidelines that 
followed are based on the "best practice" notion. 
Unlike Germany, the USA view individualism in their society as a reason for its 
greatness (Wilhelm & Chaichompoo, 2016). The United States ranked first among 
50 nations and three regions on the individualism-collectivism continuum with an 
IDV index score of 91 (Hofstede, 2001). The trademark of such a society is that the 
ties between the individual and society are loose, and the relationship between the 
employer and employee is strictly a business agreement (Hofstede, 2001; Bhagat, 
2002).  
Another aspect of the American culture is the high score on the power distance and 
masculinity dimension. This allows bringing in leaders who lead more by 
inspiration than technical competence; it allows their skill set to be more 
generalized (Wilhelm & Chaichompoo, 2016). The values attributed to leadership 
include integrity, accountability, empathy, humility, resilience, vision, and 
influence. An example of such a leader would be Elon Musk. As an individual, he 
does not possess a direct knowledge of engineering or manufacturing of the 
product. However, he is actively and effectively handling a multinational 
automobile company and space agency. 
Bridging the Gap in HRM 
Modern technology can bridge the differences between the two cultures by having 
more frequent and professional interactions with employees using email, 
videoconferencing, and other tools at the multinational corporation's disposal. It is 
a challenge for any company to continue sharing its ideas, goals, and policies across 
nations with its vast array of employees. Such will be the challenge for BluBird Bio 
during the establishment of headquarters in Germany. An important aspect of 
laying down a positive foundation of the multinational corporation's goals will be 
to establish a transition team comprised of both a parent country nationals and a 
host country nationals. This leadership team will be able to navigate through the 
issues that will emerge during the initial stages of production. The choice of parent 
country nationals for the leadership team has to be made in such a way to have 
merit in the view of German leadership; meaning the person in a leadership position 
has to be proficient in the work that will be performed in the organization, such 
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positions have to be filled by investigators and clinical scientist that are well 
familiar with the issue.  
After the transition team has finished the groundwork for establishing the 
headquarters, technology in HRM will be used extensively to propagate the goals 
and policies of the organization. Communications through email, 
videoconferences, virtual training sessions, etc., are valuable tools in transferring 
knowledge and policies through the multinational corporation. As research and 
development of BlueBird Bio is fragmented through multiple countries of North 
America and Europe, the use of emails to and from conferences are imperative to 
share knowledge throughout the organizations. Employees in Great Britain can 
conduct studies in laboratories and share information on treatment production in 
North Carolina. Furthermore, patient sample acquisition logistics in countries 
(France, Britain, and the US) need direct communication in real-time for the 
production to be efficient.  
Since technology has created greater availability of information, third-country 
nationals can have direct instruction in managing resources that align with 
multinational corporation's objectives. Leadership between the US and Germany 
can come to uniform policies between nations that will maintain the organization's 
direction and address any local issue that might surface.  
Besides organizing face-to-face meetings, BlueBird Bio can use videoconferencing 
as a less expensive way to provide training for its employees. Education in the 
domains of production and quality control, as well as in leadership, can be 
conducted globally using technology. Employees in Germany can relate questions 
to their counterparts in North Carolina and adjust procedures for better efficiency 
or quality. The knowledge does not only flow in a singular direction, and parent 
country nationals can learn new approaches to problem-solving from their German 
counterparts.  
Although technology can provide a more economic and frequent path in dealing 
with decentralization and global interaction in multinational corporations, there is 
still no substitute for international assignments for both host country national and 
parent country nationals. Besides transferring formal policies and procedures, real 
human interaction is necessary for gaining perspective of the environment and its 
influencing factors. Therefore, it is important to have a transfer of parent country 
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nationals into host countries, as well as host country nationals into parent countries. 
In terms of BlueBird Bio, it is of high importance that parent country nationals 
experience significant time in the new German Headquarters as the cultural 
differences in employment, leadership, and institution are not easily related 
virtually. Furthermore, employees from Germany would benefit from short-term 
assignments into the US, as the transfer of tacit knowledge is inefficient in 
impersonal means.  
Conclusion 
It is no doubt that entering the German market will expose some "country of origin" 
effects in initial policymaking by BlueBird Bio. This will be the ways the company 
is used to deal with issues within the parent country; issues such as industrial 
relations, training and education, the welfare state, the nature of inter-firm and intra-
firm coordination within the economy, the firm-level division of labor and of 
management roles, and the nature of corporate finance (Almond, 2005). Unlike the 
United States, Germany still abides by the old "German Model." Company culture 
is more organized, and production-oriented capitalism implies a greater concern 
with, and closer integration of, management and labor around productive tasks, as 
well as reflecting a more communitarian approach towards problem resolution 
(Lane, 1998). Organizations are further reinforced by a system of education and 
training, which puts a strong emphasis on skill development at all levels of the 
industrial hierarchy. German employees might find BlueBird bio's education perks 
quite helpful as they range from covering the costs of seminars to full tuition 
reimbursement.  
As BlueBird Bio is funded in the United States, it will demonstrate HRM policies 
commonly practiced within the US. Here, the culture is largely individualistic, with 
employees generally highly motivated by their careers (Taylor & Zhou, 2019). The 
US culture is also more prone to taking risks and approaching solutions through 
trial and error. With this in mind, the initial stages of establishing the German 
Headquarters will require effort to understand the culture and institutional effects 
of the working environment. This is of great importance to be competitive for 
human capital on the German market. The leadership team needs to be a joint effort 
of parent country nationals, and host country nationals as the leadership styles vary 
significantly between the two countries, evident from the Daimler-Chrysler merger 
failure. The attributes of US leadership, such as effectiveness, including 
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charismatic, team-oriented, participative, humane-oriented, self-protective and 
autonomous, will not gain the same following in Germany, where leaders are 
performance orientated, are low on compassion, self-protection, team orientation, 
are high on autonomy, and high on participation (Tuselmann, et.al, 2010). The 
success of BlueBird Bio in Germany will be dependent upon its skill to navigate 
the culture of employees, leadership, and government policies. With its existing 
international relations and employee education programs, this organization is at a 
good start for a long road ahead.  
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